A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

Abstract Nipah and Hendra viruses are highly pathogenic bat-borne paramyxoviruses recently included in the WHO Blueprint priority diseases list. A fully registered horse anti-Hendra virus subunit vaccine has been in use in Australia since 2012. Based on the same immunogen, the Hendra virus attachmen...

Full description

Bibliographic Details
Main Authors: Thomas W. Geisbert, Kathryn Bobb, Viktoriya Borisevich, Joan B. Geisbert, Krystle N. Agans, Robert W. Cross, Abhishek N. Prasad, Karla A. Fenton, Hao Yu, Timothy R. Fouts, Christopher C. Broder, Antony S. Dimitrov
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-021-00284-w

Internet

https://doi.org/10.1038/s41541-021-00284-w

Similar Items